Geode Capital Management LLC Raises Position in Cigna Group $CI

Key Points

• Geode Capital Management boosted its Cigna stake by 0.8% in the fourth quarter, ending with 6.05 million shares worth about $1.66 billion. Institutional investors remain heavily involved, with hedge funds and other institutions owning 86.99% of the company.
• Cigna reported stronger-than-expected quarterly results, posting EPS of $7.79 versus estimates of $7.60 and revenue of $68.52 billion versus expectations of $66.29 billion. The company also reaffirmed a FY 2026 EPS guidance of 30.350.
• Analysts and insiders showed mixed signals: several firms raised price targets, giving Cigna a consensus “Moderate Buy” rating with a $339.50 target, while insiders, including CEO David Cordani, sold shares in recent months. Cigna also announced a quarterly dividend of $1.56 per share, yielding 2.2% annualized.

Geode Capital Management LLC increased its holdings in Cigna Group (NYSE:CI - Free Report) by 0.8% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,051,370 shares of the health services provider's stock after buying an additional 48,474 shares during the period. Geode Capital Management LLC owned 2.27% of Cigna Group worth $1,658,055,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CI. Beacon Financial Strategies CORP purchased a new stake in shares of Cigna Group in the fourth quarter worth $28,000. Lodestone Wealth Management LLC bought a new position in Cigna Group in the fourth quarter valued at $32,000. Collier Financial bought a new position in Cigna Group in the third quarter valued at $34,000. Creative Financial Designs Inc. ADV increased its stake in Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider's stock valued at $37,000 after acquiring an additional 81 shares during the last quarter. Finally, Activest Wealth Management increased its stake in Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider's stock valued at $38,000 after acquiring an additional 126 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Cigna Group Stock Down 0.4%

Shares of NYSE:CI opened at $284.62 on Friday. The stock's 50-day moving average price is $278.07 and its 200-day moving average price is $276.88. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89. The stock has a market capitalization of $75.29 billion, a P/E ratio of 12.07, a price-to-earnings-growth ratio of 1.03 and a beta of 0.30. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to analysts' expectations of $66.29 billion. During the same period last year, the firm earned $6.74 earnings per share. The company's revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group's dividend payout ratio (DPR) is 26.45%.

Analysts Set New Price Targets

A number of research analysts recently commented on CI shares. Leerink Partners increased their target price on Cigna Group from $270.00 to $297.00 and gave the company a "market perform" rating in a research note on Friday, February 6th. Cantor Fitzgerald increased their target price on Cigna Group from $325.00 to $340.00 and gave the company an "overweight" rating in a research note on Friday, May 1st. Truist Financial increased their target price on Cigna Group from $320.00 to $350.00 and gave the company a "buy" rating in a research note on Tuesday, February 17th. Robert W. Baird set a $337.00 target price on Cigna Group in a research note on Friday, May 1st. Finally, Barclays cut Cigna Group from an "overweight" rating to an "equal weight" rating and reduced their target price for the company from $310.00 to $304.00 in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Cigna Group presently has an average rating of "Moderate Buy" and a consensus price target of $339.50.

Insider Activity

In other news, insider Everett Neville sold 1,719 shares of the firm's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider directly owned 5,670 shares of the company's stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the firm's stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 205,904 shares of company stock valued at $60,277,068. 0.60% of the stock is currently owned by insiders.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.